Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b interferon

Authors

  • Francesc-Xavier López-Labrador,

    1. Liver Unit, Department of Medecine, Institut d'Investigacions Biomèdiques August Pí i Sunyer (IDIBAPS); Universitat de Barcelona, Spain
    Current affiliation:
    1. F.-X.L.-L.: Division of Gastroenterology, Stanford University School of Medicine, Veterans Administration Medical Center, Palo Alto, CA
    Search for more papers by this author
  • Sergi Ampurdanès,

    1. Liver Unit, Department of Medecine, Institut d'Investigacions Biomèdiques August Pí i Sunyer (IDIBAPS); Universitat de Barcelona, Spain
    Search for more papers by this author
  • Mireia Giménez-Barcons,

    1. Liver Unit, Department of Medecine, Institut d'Investigacions Biomèdiques August Pí i Sunyer (IDIBAPS); Universitat de Barcelona, Spain
    Search for more papers by this author
  • Magdalena Guilera,

    1. Liver Unit, Department of Medecine, Institut d'Investigacions Biomèdiques August Pí i Sunyer (IDIBAPS); Universitat de Barcelona, Spain
    Search for more papers by this author
  • Josep Costa,

    1. Microbiology Department, Hospital Clínic, Facultat de Medicina, Universitat de Barcelona, Spain
    Search for more papers by this author
  • María Teresa Jiménez de Anta,

    1. Microbiology Department, Hospital Clínic, Facultat de Medicina, Universitat de Barcelona, Spain
    Search for more papers by this author
  • Jose M. Sánchez-Tapias,

    Corresponding author
    1. Liver Unit, Department of Medecine, Institut d'Investigacions Biomèdiques August Pí i Sunyer (IDIBAPS); Universitat de Barcelona, Spain
    • Liver Unit, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain. fax: 34-93-4515272
    Search for more papers by this author
  • Juan Rodés,

    1. Liver Unit, Department of Medecine, Institut d'Investigacions Biomèdiques August Pí i Sunyer (IDIBAPS); Universitat de Barcelona, Spain
    Search for more papers by this author
  • Juan-Carlos Sáiz

    1. Liver Unit, Department of Medecine, Institut d'Investigacions Biomèdiques August Pí i Sunyer (IDIBAPS); Universitat de Barcelona, Spain
    Search for more papers by this author

Abstract

In patients with chronic hepatitis C, the influence of the genetic heterogeneity of the hepatitis C virus (HCV) on the progression of liver disease and on the responsiveness to interferon therapy is a matter of controversy. In this study we evaluated the genetic complexity of HCV by single-strand conformation polymorphism (SSCP) analysis of amplicons from the hypervariable region 1 (HVR1) in 168 patients with chronic genotype 1b HCV infection, of whom 122 received a single course of interferon therapy (3 MU, three times weekly for 6 months). No correlation was observed between the degree of genetic complexity of HCV (indicated by the number of bands in the SSCP assay) and patient age, serum alanine aminotransferase activity, or serum HCV-RNA concentration, measured by competitive polymerase chain reaction. HCV genomic complexity was not related to gender nor to the presumed source of infection. The number of SSCP bands detected in serum samples from patients with chronic hepatitis, either mild (8.1 ± 3.9), moderate (8.0 ± 3.3), or severe (9.2 ± 3.3), and in patients with liver cirrhosis, either compensated (8.0 ± 2.9), decompensated (6.3 ± 2.9), or with superimposed hepatocellular carcinoma (9.5 ± 2.9), was similar. The number of SSCP bands detected in patients with sustained response (7.5 ± 3.9), transient response (8.3 ± 2.9), or no response (8.2 ± 3.6) to interferon administration was similar as well. These observations suggest that the genetic complexity of hypervariable region (HVR1) of HCV, as estimated by SSCP analysis, is not related to the severity of liver injury nor to the type of response to interferon therapy. Thus, information offered by SSCP analysis of HVR1 of HCV in chronic HCV genotype 1b infection does not appear to be useful in the clinical management of these patients.

Ancillary

Advertisement